secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mereo BioPharma Group plc (MREO)
CIK:        0001719714
Form:       8-K
Filed at:   2025-05-14T23:59:59+00:00
Accession:  0000950170-25-071485
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mereo BioPharma 2025 AGM: all resolutions pass; board elects annual say-on-pay
------------------------------------------------------------------------------

- Resolutions 1-5 and 7-9 passed with over 85% of votes cast.
- Resolution 6 (advisory vote on frequency of exec comp) received 48% for 1-year, 46% for 3-year; board chooses annual frequency until 2031.
- Re-elected directors Deepika Pakianathan, Pierre Jacquet, Michael Wyzga each won >85% support.
- PricewaterhouseCoopers re-appointed as auditor with 99.58% of votes cast.
- Total 624,188,662 ordinary shares represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1719714/000095017025071485/0000950170-25-071485-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1719714/000095017025071485/mreo-20250513.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-071485

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer